Enara Bio’s presentation on development of an MR1-targeting T cell therapy from the 12th International CD1-MR1 EMBO Meeting
Director of MR1 Biology Dr. Jon Silk and Vice President, Head of Research Dr. Joe Dukes presented data on Enara Bio’s lead program at the 12th International CD1-MR1 EMBO Meeting in Gothenburg from May 23-26, 2022
Download the file